Singular Genomics Systems Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	30.12	16.23	74.27	201.05	11.69	5.5
Short-Term Investments	103.27	159.17	170.93	138.94	15.26	40.7
Cash & Short-Term Investments	133.39	175.4	245.2	339.98	26.95	46.2
Cash Growth	-35.62%	-28.47%	-27.88%	1161.44%	-41.66%	-
Accounts Receivable	0.44	0.57	0.91	-	-	-
Other Receivables	0.89	1.02	1.1	1.05	0.02	-
Receivables	1.33	1.58	2.01	1.05	0.02	-
Inventory	12.44	13.57	18.22	3.01	-	-
Prepaid Expenses	1.54	1.67	3	3.72	0.6	0.26
Total Current Assets	148.7	192.23	268.43	347.76	27.57	46.46
Property, Plant & Equipment	69.63	71.49	56.68	6.07	2.37	1.61
Other Long-Term Assets	1.68	1.75	2.86	1.82	0.56	0.1
Total Assets	220	265.47	327.98	355.65	30.5	48.17
Accounts Payable	1.5	2.59	3.1	2.35	0.43	0.56
Accrued Expenses	4.05	6.08	4.58	4.28	1.59	0.46
Current Portion of Long-Term Debt	3.94	-	-	-	0.93	-
Current Portion of Leases	7.07	7.76	6.32	-	-	-
Other Current Liabilities	0.4	1.86	0.11	0.12	0.75	0.09
Total Current Liabilities	16.95	18.29	14.12	6.74	3.69	1.11
Long-Term Debt	6.36	8.9	10.07	9.9	8.47	2.4
Long-Term Leases	58.37	58.62	42.46	-	-	-
Other Long-Term Liabilities	0.62	0.65	1.02	2.83	0.71	0.17
Total Liabilities	82.3	86.46	67.65	19.48	12.87	3.69
Common Stock	-	0.01	0.01	0.01	0	0
Additional Paid-In Capital	521.65	516.44	503.93	488.2	1.55	0.44
Retained Earnings	-383.87	-337.6	-242.78	-151.9	-53.13	-25.18
Comprehensive Income & Other	-0.07	0.16	-0.84	-0.14	0.02	0.01
Total Common Equity	137.71	179.01	260.32	336.17	-51.56	-24.73
Shareholders' Equity	137.71	179.01	260.32	336.17	17.63	44.49
Total Liabilities & Equity	220	265.47	327.98	355.65	30.5	48.17
Total Debt	75.73	75.29	58.84	9.9	9.4	2.4
Net Cash (Debt)	57.66	100.11	186.35	330.08	17.56	43.8
Net Cash Growth	-61.24%	-46.28%	-43.54%	1780.05%	-59.91%	-
Net Cash Per Share	23.45	41.26	78.58	210.59	49.80	152.42
Filing Date Shares Outstanding	2.5	2.46	2.4	2.35	0.36	0.29
Total Common Shares Outstanding	2.49	2.46	2.4	2.41	0.36	0.29
Working Capital	131.75	173.94	254.31	341.02	23.88	45.35
Book Value Per Share	55.27	72.74	108.69	139.22	-142.98	-86.05
Tangible Book Value	137.71	179.01	260.32	336.17	-51.56	-24.73
Tangible Book Value Per Share	55.27	72.74	108.69	139.22	-142.98	-86.05
Machinery	21.08	19.47	13.22	6.64	3.53	2.19
Construction In Progress	-	-	-	0.57	-	-
Leasehold Improvements	2.24	2.24	2.13	1.04	0.08	0.03

Source: S&P Capital IQ. Standard template. Financial Sources.